Supreme Court Closes Term With Actions On Several Pharma Cases, Including Universities' Rights Under Bayh-Dole
This article was originally published in The Pink Sheet Daily
Executive Summary
The court's orders address Stanford University's suit against Roche Molecular, Pfizer's petition to review Trovan case, and jurisdiction over antitrust claims in a patent dispute.
You may also be interested in...
Supreme Court Gets Nudge On Bayh-Dole Case; Denies HRT Petition; Will Review Infringement “State Of Mind”
The Solicitor General has urged the Supreme Court to take up a case questioning whether an inventor can eliminate a university’s rights to federally funded research by making an agreement with a third party.
Supreme Court Gets Nudge On Bayh-Dole Case; Denies HRT Petition; Will Review Infringement “State Of Mind”
The Solicitor General has urged the Supreme Court to take up a case questioning whether an inventor can eliminate a university’s rights to federally funded research by making an agreement with a third party.
Supreme Court Loosens Rule On What Processes Can Be Patented
To the relief of the biotechnology industry, the court rules in the Bilski case that a process need not be tied to a machine or transform an article to be patented.